TGFB1 and pulmonary fibrosis: NFA treatment not only impedes the pro-fibrotic effects of TGFβ but also facilitates the breakdown of collagen and reverses the transdifferentiation of myofibroblasts, ultimately ameliorating established pulmonary fibrosis in mice [61].